ART26.12, an FABP5 Inhibitor, Shows Efficacy in Preclinical Psoriasis Models

Published in: Journal of Investigative Dermatology

Volume 145, Issue 10, pp. 2510-2523.e1

DOI: 10.1016/j.jid.2025.03.026